Outshine NW has worked with researchers at University of Washington, UCLA, UCSF, Fred Hutch, and more to improve scientific reliability by more accurately characterizing and including transgender people in clinical research. Brandyn Gallagher serves on the Cross Network Transgender Working Group for the National Institute of Allergy and Infectious Disease’s Division of AIDS, providing collaborative insight and crafting network-wide recommendations that impact AIDS Clinical Trials Group (ACTG), HIV Prevention Trials Network (HPTN), HIV Vaccine Trials Network (HVTN), International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT), International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), and Microbicide Trials Network (MTN).